Biomedical applications of chitosan and its derivative nanoparticles

D Zhao, S Yu, B Sun, S Gao, S Guo, K Zhao - Polymers, 2018 - mdpi.com
Chitosan is a biodegradable natural polymer with many advantages such as nontoxicity,
biocompatibility, and biodegradability. It can be applied in many fields, especially in …

Advances in gene-based vaccine platforms to address the COVID-19 pandemic

D Pushparajah, S Jimenez, S Wong, H Alattas… - Advanced drug delivery …, 2021 - Elsevier
The novel betacoronavirus, SARS-CoV-2 (severe acute respiratory syndrome coronavirus
2), has spread across the globe at an unprecedented rate since its first emergence in Wuhan …

Biomaterials for nanoparticle vaccine delivery systems

P Sahdev, LJ Ochyl, JJ Moon - Pharmaceutical research, 2014 - Springer
Subunit vaccination benefits from improved safety over attenuated or inactivated vaccines,
but their limited capability to elicit long-lasting, concerted cellular and humoral immune …

Technologies for enhanced efficacy of DNA vaccines

F Saade, N Petrovsky - Expert review of vaccines, 2012 - Taylor & Francis
Despite many years of research, human DNA vaccines have yet to fulfill their early promise.
Over the past 15 years, multiple generations of DNA vaccines have been developed and …

Towards the future exploration of mucosal mRNA vaccines against emerging viral diseases; lessons from existing next-generation mucosal vaccine strategies

SA Hameed, S Paul, GKY Dellosa, D Jaraquemada… - npj Vaccines, 2022 - nature.com
The mRNA vaccine platform has offered the greatest potential in fighting the COVID-19
pandemic owing to rapid development, effectiveness, and scalability to meet the global …

[HTML][HTML] Influenza neuraminidase characteristics and potential as a vaccine target

S Creytens, MN Pascha, M Ballegeer… - Frontiers in …, 2021 - frontiersin.org
Neuraminidase of influenza A and B viruses plays a critical role in the virus life cycle and is
an important target of the host immune system. Here, we highlight the current understanding …

Engineered nanodelivery systems to improve DNA vaccine technologies

M Lim, AZM Badruddoza, J Firdous, M Azad, A Mannan… - Pharmaceutics, 2020 - mdpi.com
DNA vaccines offer a flexible and versatile platform to treat innumerable diseases due to the
ease of manipulating vaccine targets simply by altering the gene sequences encoded in the …

Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens

F Wegmann, KH Gartlan, AM Harandi… - Nature …, 2012 - nature.com
Protection against mucosally transmitted infections probably requires immunity at the site of
pathogen entry 1, yet there are no mucosal adjuvant formulations licensed for human use …

Transfection efficiency and transgene expression kinetics of mRNA delivered in naked and nanoparticle format

KKL Phua, KW Leong, SK Nair - Journal of Controlled Release, 2013 - Elsevier
Transfection efficiencies and transgene expression kinetics of messenger RNA (mRNA), an
emerging class of nucleic acid-based therapeutics, have been poorly characterized. In this …

Delivery methods to increase cellular uptake and immunogenicity of DNA vaccines

SHT Jorritsma, EJ Gowans, B Grubor-Bauk… - Vaccine, 2016 - Elsevier
DNA vaccines are ideal candidates for global vaccination purposes because they are
inexpensive and easy to manufacture on a large scale such that even people living in low …